Lexaria Bioscience (LEXX) vs Medicus Pharma (MDCX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Medicus Pharma is the larger company by market cap ($7.3 million vs $6.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | LEXX | MDCX |
|---|---|---|
| Share price | $3.20 | $0.1019 |
| Market cap | $6.74M | $7.31M |
| 1-day change | -8.57% | -36.39% |
| YTD return | — | -89.53% |
| 1-year return | — | -93.38% |
| EPS (TTM) | $-5.10 | $-2.38 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $21.60 | $2.78 |
| 52-week low | $2.77 | $0.0941 |
| Distance from 52-week high | -85.19% | -96.33% |
| Average volume | 62.08K | 4.43M |
| Shares outstanding | 2.11M | 71.71M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
LEXX vs MDCX FAQ
Which is bigger, Lexaria Bioscience or Medicus Pharma?
Medicus Pharma (MDCX) is larger, with a market capitalization of $7.31M compared with $6.74M for Lexaria Bioscience (LEXX).
Are Lexaria Bioscience and Medicus Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.